WOOJUNG BIO Total Debt vs. Revenue

215380 Stock  KRW 1,675  23.00  1.35%   
Considering WOOJUNG BIO's profitability and operating efficiency indicators, WOOJUNG BIO may not be well positioned to generate adequate gross income at the moment. It has a very high risk of underperforming in January. Profitability indicators assess WOOJUNG BIO's ability to earn profits and add value for shareholders.
For WOOJUNG BIO profitability analysis, we use financial ratios and fundamental drivers that measure the ability of WOOJUNG BIO to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well WOOJUNG BIO utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between WOOJUNG BIO's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of WOOJUNG BIO over time as well as its relative position and ranking within its peers.
  
Check out Trending Equities.
Please note, there is a significant difference between WOOJUNG BIO's value and its price as these two are different measures arrived at by different means. Investors typically determine if WOOJUNG BIO is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, WOOJUNG BIO's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

WOOJUNG BIO Revenue vs. Total Debt Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining WOOJUNG BIO's current stock value. Our valuation model uses many indicators to compare WOOJUNG BIO value to that of its competitors to determine the firm's financial worth.
WOOJUNG BIO is rated second in total debt category among its peers. It is rated fourth in revenue category among its peers totaling about  1.11  of Revenue per Total Debt. Comparative valuation analysis is a catch-all model that can be used if you cannot value WOOJUNG BIO by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for WOOJUNG BIO's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

WOOJUNG Total Debt vs. Competition

WOOJUNG BIO is rated second in total debt category among its peers. Total debt of Biotechnology & Medical Research industry is presently estimated at about 88.42 Billion. WOOJUNG BIO totals roughly 28.1 Billion in total debt claiming about 32% of stocks in Biotechnology & Medical Research industry.
Total debt  Capitalization  Valuation  Revenue  Workforce

WOOJUNG Revenue vs. Total Debt

Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.

WOOJUNG BIO

Total Debt

 = 

Bonds

+

Notes

 = 
28.1 B
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.

WOOJUNG BIO

Revenue

 = 

Money Received

-

Discounts and Returns

 = 
31.24 B
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.

WOOJUNG Revenue vs Competition

WOOJUNG BIO is rated fourth in revenue category among its peers. Market size based on revenue of Biotechnology & Medical Research industry is presently estimated at about 201.98 Billion. WOOJUNG BIO retains roughly 31.24 Billion in revenue claiming about 15% of stocks in Biotechnology & Medical Research industry.

WOOJUNG BIO Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in WOOJUNG BIO, profitability is also one of the essential criteria for including it into their portfolios because, without profit, WOOJUNG BIO will eventually generate negative long term returns. The profitability progress is the general direction of WOOJUNG BIO's change in net profit over the period of time. It can combine multiple indicators of WOOJUNG BIO, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
WOOJUNG BIO, Inc. provides research and laboratory services in Korea. WOOJUNG BIO, Inc. was founded in 1989 and is based in Suwon, South Korea. WOOJUNG BIO is traded on Korean Securities Dealers Automated Quotations in South Korea.

WOOJUNG Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on WOOJUNG BIO. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of WOOJUNG BIO position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the WOOJUNG BIO's important profitability drivers and their relationship over time.

Use WOOJUNG BIO in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if WOOJUNG BIO position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in WOOJUNG BIO will appreciate offsetting losses from the drop in the long position's value.

WOOJUNG BIO Pair Trading

WOOJUNG BIO Pair Trading Analysis

The ability to find closely correlated positions to WOOJUNG BIO could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace WOOJUNG BIO when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back WOOJUNG BIO - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling WOOJUNG BIO to buy it.
The correlation of WOOJUNG BIO is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as WOOJUNG BIO moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if WOOJUNG BIO moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for WOOJUNG BIO can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your WOOJUNG BIO position

In addition to having WOOJUNG BIO in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Financials Thematic Idea Now

Financials
Financials Theme
Companies that provide financial services to business or retail customers. The Financials theme has 20 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Financials Theme or any other thematic opportunities.
View All  Next Launch

Other Information on Investing in WOOJUNG Stock

To fully project WOOJUNG BIO's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of WOOJUNG BIO at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include WOOJUNG BIO's income statement, its balance sheet, and the statement of cash flows.
Potential WOOJUNG BIO investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although WOOJUNG BIO investors may work on each financial statement separately, they are all related. The changes in WOOJUNG BIO's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on WOOJUNG BIO's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.